Walgreens Boots Alliance (NASDAQ:WBA) Issues FY 2025 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share guidance of 1.400-1.800 for the period, compared to the consensus earnings per share estimate of 1.520. The company issued revenue guidance of -. Walgreens Boots Alliance also updated its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Price Performance

Walgreens Boots Alliance stock opened at $11.76 on Friday. The business’s fifty day moving average is $9.26 and its two-hundred day moving average is $9.85. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The firm has a market cap of $10.15 billion, a P/E ratio of -1.17, a P/E/G ratio of 1.36 and a beta of 0.64. Walgreens Boots Alliance has a 52 week low of $8.08 and a 52 week high of $24.93.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter in the prior year, the firm earned $0.66 EPS. The company’s revenue was up 7.6% on a year-over-year basis. Equities research analysts forecast that Walgreens Boots Alliance will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 8.50%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is -9.99%.

Analysts Set New Price Targets

WBA has been the topic of several analyst reports. UBS Group increased their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Truist Financial reduced their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Barclays upped their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 16th. Evercore ISI raised their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. Finally, Morgan Stanley reduced their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.